-
公开(公告)号:US4209444A
公开(公告)日:1980-06-24
申请号:US855591
申请日:1977-11-29
IPC分类号: A61K31/20 , A61K31/215 , A61P43/00 , C07C67/00 , C07C401/00 , C07C405/00 , C07D317/72 , C07D319/08 , C07C177/00
CPC分类号: C07D317/72 , C07C405/00 , C07D319/08
摘要: Compounds of formula ##STR1## their mirror images and racemic mixtures, and the physiologically acceptable salts thereof,wherein A and D each are ketalized carbonyl groups; B is --CH.sub.2 --, --CH(CH.sub.3)--, --C(CH.sub.3).sub.2 --, --CH.sub.2 CH.sub.2 --, --CH(CH.sub.3)CH.sub.2 ----C(CH.sub.3).sub.2 CH.sub.2 -- or --CH.sub.2 O--; R.sup.1 is H or alkyl of 1-4 C-atoms; and R.sup.2 is alkyl of 3 to 5 C-atoms, phenyl or phenyl substituted one to three times by F, Cl, CF.sub.3, OH, OCH.sub.3, OC.sub.2 H.sub.5 or alkyl of 1 to 3 C-atoms inhibit aggregation and/or adhesion of thrombocytes.
摘要翻译: 式I化合物是其镜像和外消旋混合物及其生理上可接受的盐,其中A和D各自为缩酮化羰基; B是-CH 2 - , - CH(CH 3) - , - C(CH 3)2 - , - CH 2 CH 2 - , - CH(CH 3)CH 2 -C(CH 3)2 CH 2 - 或-CH 2 O- R1是H或1-4个C原子的烷基; R 2为3〜5个C原子的烷基,苯基或被F,Cl,CF 3,OH,OCH 3,OC 2 H 5或1〜3个C原子的烷基取代1〜3次的苯基或苯基,可抑制凝血细胞的聚集和/或粘附。
-
公开(公告)号:US4125622A
公开(公告)日:1978-11-14
申请号:US860355
申请日:1977-12-14
IPC分类号: A61K31/39 , A61P7/02 , C07D327/06
CPC分类号: C07D327/06 , Y10S514/822
摘要: 1,4-Oxathianes of the formula ##STR1## and the physiologically-acceptable salts thereof wherein R.sup.1 is H or alkyl with 1-4 C-atoms; R.sup.2 is H or alkyl with 1-4 C-atoms; R.sup.3 is H, alkyl with 1-8 C-atoms, phenyl or phenyl substituted by F, Cl, Br, OH, OCH.sub.3, CF.sub.3 or NO.sub.2 ; R.sup.4 is H or CH.sub.3 ; B is a single bond, --CH.sub.2 --, --CH.sub.2 CH.sub.2 -- or --CH.sub.2 O--; and a wavy line ( ) indicates that these bonds can be in the .alpha.- or .beta.- positions possess thrombocyte inhibition properties.
摘要翻译: 具有式“IMAGE”的1,4-氧硫辛酸和其生理学上可接受的盐,其中R 1是H或具有1-4个C原子的烷基; R2是H或具有1-4个C原子的烷基; R3是H,具有1-8个C原子的烷基,被F,Cl,Br,OH,OCH3,CF3或NO2取代的苯基或苯基; R4是H或CH3; B是单键,-CH 2 - , - CH 2 CH 2 - 或-CH 2 O- 和波浪线()表示这些键可以在α或β位具有血细胞抑制性质。
-
公开(公告)号:US4188403A
公开(公告)日:1980-02-12
申请号:US863001
申请日:1977-12-21
IPC分类号: A61K31/13 , A61K20060101 , A61K31/135 , A61K31/195 , A61K31/21 , A61K31/215 , A61K31/22 , A61K31/27 , A61K31/325 , A61P43/00 , C07C20060101 , C07C67/00 , C07C213/00 , C07C217/52 , C07C227/00 , C07C227/08 , C07C227/16 , C07C227/18 , C07C229/14 , C07C239/00 , C07C271/24 , C07C91/16
CPC分类号: A61K31/135
摘要: Compounds of the Formula ##STR1## and the physiologically acceptable salts thereof, wherein R.sup.1 and R.sub.2 each is hydrogen or benzyl; R.sup.3 is alkyl of 5-10 C-atoms or 2-hydroxyalkyl of 5-10 C-atoms; R.sup.4 is hydrogen, methyl or ethyl; R.sup.5 is alkyl of 5-10 C-atoms or --C.sub.n H.sub.2n COOR.sup.6 ; R.sup.6 is hydrogen or alkyl of 1-4 C-atoms; and n is 0, 4, 5 or 6 are effective for inhibiting adhesion and/or agglomeration of thrombocytes.
摘要翻译: 式“IMAGE”的化合物及其生理上可接受的盐,其中R 1和R 2各自为氢或苄基; R3是5-10个C原子的烷基或5-10个C原子的2-羟基烷基; R4是氢,甲基或乙基; R5是5-10个C原子的烷基或-CnH2nCOOR6; R6是氢或1-4个C原子的烷基; 并且n为0,4,5或6对于抑制凝血细胞的粘附和/或附聚是有效的。
-
公开(公告)号:US4080446A
公开(公告)日:1978-03-21
申请号:US738952
申请日:1976-11-04
IPC分类号: C07D263/16 , A61K31/42 , A61K31/421 , A61P7/02 , A61K31/625
摘要: 2-(4,5-BIS-P-CHLOROPHENYLOXAZOL-2-YL-MERCAPTO)-PROPIONIC ACID AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS IS USEFUL FOR SUPPRESSING AGGREGATION OF THROMBOCYTES, PARTICULARLY WHEN ADMINISTERED IN COMBINATION WITH ASPIRIN.
摘要翻译: 2-(4,5-BIS-P-CHLOROPHENYLOXAZOL-2-YL-MERCAPTO) - 丙酸及其生理上可接受的盐有助于抑制血小板聚集,特别是与ASPIRIN组合施用时。
-
-
-